Solid Biosciences Inc. SLDB Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s total liabilities & equity?
- Solid Biosciences Inc. (SLDB) reported total liabilities & equity of $422.89M in Q1 2026.
- How has Solid Biosciences Inc.'s total liabilities & equity changed year-over-year?
- Solid Biosciences Inc.'s total liabilities & equity increased by 23.0% year-over-year, from $343.9M to $422.89M.
- What is the long-term trend for Solid Biosciences Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s total liabilities & equity has grown at a 6.3% compound annual growth rate (CAGR), from $171.17M to $232.54M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.